Pasar al contenido principal

APLICACION DE NUEVAS TECNOLOGIAS EN EL PROCESADO DE SUBPRODUCTOS LACTEOS PARA LA OBTENCION DE FRACCIONES BIOACTIVAS PARA LA MEJORA DE LA SALUD INTESTINAL

PID2022-139104OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE ZARAGOZA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 9
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Effects of kefirs made from whole milk or whey on the pancreas-intestine axis in a mouse model of acute pancreatitis

  • Aguirre-Ramírez, Diego
  • Abás, Elisa
  • Gómez, Álex
  • Luján, Lluís
  • Pérez, Estela
  • Sánchez, Lourdes
  • Grasa, Laura
[Background]: acute pancreatitis (AP) is a severe inflammatory condition, often involving intestinal barrier dysfunction. Fermented foods like kefir, are potential therapeutic adjuvants due to their gut-modulatory properties. This study aimed to compare the protective effects of kefir made from pasteurized whole milk (PMK) or whey (WK) on pancreatic injury, intestinal barrier integrity, inflammation, and oxidative stress in a cerulein-induced mouse model of AP., [Methods]: male BALB/c mice were assigned to six groups: control, AP, PMK, WK, and AP combined with either PMK or WK. AP was induced by cerulein injections on days 10 and 11. Mice received kefir or saline via oral gavage for 14 days. Pancreatic and ileal tissues were analyzed for histopathological damage, serum amylase and lipase levels, gene expression of inflammatory and tight junction markers (TNF-α, IL-6, IL-1β, occludin, ZO-1), oxidative stress (MDA, carbonyls), and intestinal function., [Results]: AP induction was confirmed by elevated serum amylase/lipase and severe pancreatic damage. While both PMK and WK partially reduced pancreatic histopathological damage, they failed to reduce serum amylase and lipase levels. Furthermore, PMK, but not WK, partially attenuated pancreatic IL-6 and IL-1β expression, and both kefirs reduced ileal TNF-α. However, neither kefir prevented the AP-induced downregulation of tight junction genes, the increase in oxidative stress markers in either tissue, or the impairment of intestinal transit and contractility., [Conclusion]: kefir supplementation offers localized anti-inflammatory benefits in a severe AP model. It is insufficient to mitigate key systemic markers of pancreatic injury, restore gut barrier integrity, or reverse functional dysmotility. These findings suggest that the therapeutic potential of kefir may be limited in the context of severe acute inflammatory conditions., This work was funded by the European Union and the Spanish State Research Agency under project PID2022-139104OB-I00 and the Gobierno de Aragón (A20_23R). D. Aguirre-Ramírez was supported by a grant by the European Union Next-Generation EU., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Antirotaviral activity of dairy byproducts enriched in fractions from hyperimmune bovine colostrum: the effect of thermal and high hydrostatic pressure treatments

  • Graikini, Dimitra
  • García, Laura
  • Abad, Inés
  • Lavilla, María
  • Puértolas, Eduardo
  • Pérez, María Dolores
  • Sánchez, Lourdes
Nowadays, rotaviruses remain a major health burden, especially in developing countries, and strategies complementary to vaccination are needed. In this view, dairy fractions have attracted great scientific interest, due to their high content of bioactive compounds. The objective of this study was to evaluate the antiviral activity of whey and buttermilk enriched in proteins from hyperimmune bovine colostrum (HBC) against rotavirus. The enriched fractions were spray-dried and subsequently tested for their neutralizing activity against the bovine rotavirus WC3 strain in vitro, using differentiated Caco-2/TC7 cells. The highest antirotaviral activity was observed when whey and buttermilk were enriched in purified immunoglobulin G (IgG), showing complete rotavirus neutralization at concentrations of 3 and 6 mg mL−1 for whey and buttermilk, respectively. Additionally, the use of a crude immunoglobulin fraction also gave satisfactory results. The inhibitory activities of all samples significantly decreased after the application of heat, except for the IgG-enriched buttermilk which showed a slight increase of activity following the application of short-time treatments (75 or 85 °C for 20 s). This sample also showed a significant increase of activity (13%) after the application of low-intensity high hydrostatic pressure treatment (400 MPa for 5 min). The maximum loss of bioactivity was observed at 600 MPa for 10 min (31 and 20% for whey- and buttermilk-based formulas, respectively). This study provides relevant information on the potential of whey, buttermilk, and HBC to be part of functional products as complementary strategies to combat rotavirus infections.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Gastrointestinal digestion and technological treatments modify the antibacterial activity of lactoferrin supplemented dairy matrices against Staphylococcus aureus

  • Abad, I.
  • Bailac, A.
  • Pérez, M.D.
  • Carramiñana, J.J.
  • Calvo, M.
  • Sánchez, L.
Milk contains antimicrobial proteins, such as lactoferrin from whey or proteins from the milk fat globule membrane (MFGM), which can be used in functional foods to strengthen children and adult defenses. Foodborne bacteria, such as Staphylococcus aureus, can contaminate dairy products causing intoxication. The aim of this study was to evaluate the antibacterial activity of lactoferrin, free and in dairy matrices, against S. aureus before and after gastrointestinal digestion. Six dairy formulas, supplemented with lactoferrin and MFGM, were subjected to technological treatments and their antibacterial effect was analyzed after in vitro digestion. Intact lactoferrin slightly reduced S. aureus growth, but its digests lost this activity. Gastric digests of non-treated or homogenized formulas reduced significantly the bacterial growth, probably due to the antimicrobial peptides generated by pepsin, while pasteurization decreased such activity. Intestinal digests showed the greatest antibacterial effect, probably due to the action of intestinal enzymes and the generated peptides.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Effect of ultra-high pressure homogenization on the antirotaviral activity of bovine milk whey

  • Graikini, Dimitra
  • Alvarez-Sabatel, Saioa
  • Puértolas, Eduardo
  • Pérez, María Dolores
  • Sánchez, Lourdes
In the present study, ultra-high pressure homogenization (UHPH, 100–250 MPa) was applied on bovine whey. The ability of UHPH-treated whey to neutralize the bovine rotavirus strain WC3 was evaluated in vitro using a model of human intestinal epithelium. Results showed that whey homogenized at 100 and 200 MPa inhibited the rotavirus infection in a dose-response way, exhibiting >95% neutralization at 1.5 mg mL−1 protein concentration. However, after homogenization of whey at 250 MPa, a clear neutralization pattern could not be observed. This could be attributed to aggregation and/or denaturation of some bioactive proteins, as it has been evidenced in the electrophoretic profile of that sample. Interestingly, the fat fraction obtained from all UHPH-treated wheys, showed almost complete neutralization at 1 mg mL−1 protein concentration. Therefore, whey fractions could be used as functional ingredients in novel non-thermal processed products for the control of viral infections. Industrial relevance This study provides useful information to increase the commercial value of sweet, skimmed whey as a functional ingredient and its recognition as a natural source of antivirals. The use of emerging processing technologies, such as UHPH, could favor the preservation of certain bioactivity within the dairy by-product.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Modulation of intestinal microbiota through kefir‐based beverages in a Murine model of acute pancreatitis

  • Aguirre Ramírez, Diego
  • Garrido, María
  • Sánchez, Lourdes
  • Grasa, Laura
Acute pancreatitis (AP) severely disrupts gut microbiota, leading to dysbiosis. This study investigated whether kefir derived from pasteurized whole milk (PMK) or whey (WK) could mitigate AP-induced gut microbiota alterations and promote gut health in a murine model. Male BALB/cJRj mice were assigned to CONTROL, AP-induced (PAN), PMK, WK, PMKPAN, or WKPAN groups. Fecal bacterial DNA was analyzed via 16S rRNA sequencing. AP induction caused characteristic dysbiosis, increasing Marinifilaceae, Tannerellaceae, Odoribacter, and Parabacteroides. In AP mice, PMK treatment significantly reduced Tannerellaceae and Parabacteroides, while increasing potentially anti-inflammatory Marinifilaceae and butyrate-producing Odoribacter. In healthy mice, PMK reduced pro inflammatory Desulfovibrionaceae and Bilophila, enriching short-chain fatty acid (SCFA) producers like Acetatifactor and Roseburia, with pathway analysis showing increased acetate kinase activity. WK treatment in healthy animals also promoted SCFA-producers (Acetatifactor, Odoribacter) and Muribaculaceae. In the AP model, WK upregulated bacteria involved in fatty acid biosynthesis pathways. Dairy-based kefir, particularly PMK, demonstrates a significant capacity to counteract AP-induced gut microbiota imbalances. These findings highlight kefir's nutritional relevance as a functional food with potential preventive and therapeutic applications for supporting gut health in the context of AP.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Differential protective effects of whole and skimmed whey on LPS-induced barrier dysfunction and inflammation in Caco-2/TC7 cells

  • Layunta, Elena
  • García, Laura
  • Gimeno, Sofía
  • Martínez, Jaime
  • Sánchez, Lourdes
  • Gras, Laura
Background: Lipopolysaccharide (LPS) from Gram-negative bacteria disrupts intestinal epithelial integrity and promotes inflammation, contributing to the pathogenesis of gastrointestinal disorders. Dairy-based whey products are rich in bioactive compounds with known barrier-protective and immunomodulatory properties.  Objective: This study aimed to evaluate the effects of two types of bovine whey — bovine whole whey (BWW) and bovine skimmed whey (BSW) — on LPS-induced barrier dysfunction and inflammation in the intestinal in vitro model Caco-2/TC7 cells.  Methods: Caco-2/TC7 cell line was exposed to 20 µg/ml LPS for 24h to induce epithelial barrier disruption. Additionally, cells were treated with 5 mg/ml BWW or 5 mg/ml BSW alone, or in combination with 20 µg/ml LPS. Transepithelial electrical resistance (TEER), FITC-dextran permeability, and mRNA expression of tight junction (TJ) proteins (ZO-1, claudin-1, claudin-3, occludin) and inflammation-related genes (IL-1R, COX-2, iNOS) were assessed.  Results: LPS significantly reduced TEER without increasing macromolecular permeability or altering TJ gene expression. Both whey fractions restored TEER to control levels, with BSW also enhancing baseline barrier integrity. BWW and BSW upregulated ZO-1 and claudin-1 mRNA expression, though claudin-1 was downregulated when BSW was combined with LPS. Importantly, only BWW normalized LPS-induced overexpression of IL-1R, COX-2, and iNOS, indicating better anti-inflammatory properties likely due to its retained lipid components. Conclusion: Both whey fractions reinforce epithelial barrier function under LPS challenge, but only whole whey (BWW) provides dual protection by also attenuating inflammatory responses. These findings support the potential of whole whey as a functional food ingredient for intestinal health by targeting both physical and immunological aspects of barrier dysfunction. Keywords: bovine whey, LPS, intestinal permeability, tight junction proteins, inflammation
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Effects of kefirs made from whole milk or whey on the pancreas-intestine axis in a mouse model of acute pancreatitis

  • Aguirre-Ramírez, Diego
  • Abás, Elisa
  • Gómez, Álex
  • Luján, Lluís
  • Pérez, Estela
  • Sánchez, Lourdes
  • Grasa, Laura
Background: acute pancreatitis (AP) is a severe inflammatory condition, often involving intestinal barrier dysfunction. Fermented foods like kefir, are potential therapeutic adjuvants due to their gut-modulatory properties. This study aimed to compare the protective effects of kefir made from pasteurized whole milk (PMK) or whey (WK) on pancreatic injury, intestinal barrier integrity, inflammation, and oxidative stress in a cerulein-induced mouse model of AP. Methods: male BALB/c mice were assigned to six groups: control, AP, PMK, WK, and AP combined with either PMK or WK. AP was induced by cerulein injections on days 10 and 11. Mice received kefir or saline via oral gavage for 14 days. Pancreatic and ileal tissues were analyzed for histopathological damage, serum amylase and lipase levels, gene expression of inflammatory and tight junction markers (TNF-α, IL-6, IL-1β, occludin, ZO-1), oxidative stress (MDA, carbonyls), and intestinal function. Results: AP induction was confirmed by elevated serum amylase/lipase and severe pancreatic damage. While both PMK and WK partially reduced pancreatic histopathological damage, they failed to reduce serum amylase and lipase levels. Furthermore, PMK, but not WK, partially attenuated pancreatic IL-6 and IL-1β expression, and both kefirs reduced ileal TNF-α. However, neither kefir prevented the AP-induced downregulation of tight junction genes, the increase in oxidative stress markers in either tissue, or the impairment of intestinal transit and contractility. Conclusion: kefir supplementation offers localized anti-inflammatory benefits in a severe AP model. It is insufficient to mitigate key systemic markers of pancreatic injury, restore gut barrier integrity, or reverse functional dysmotility. These findings suggest that the therapeutic potential of kefir may be limited in the context of severe acute inflammatory conditions.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Effect of homogenization and ultra-high-pressure homogenization on the activity of dairy by-products against gastrointestinal pathogens

  • García, Laura
  • Carmona, Laura
  • Casado, Rodrigo
  • Pérez, María
  • Trujillo-Mesa, Antonio
  • Hernández-Herrero, M. Manuela
  • Roig-Sagués, Artur
  • Grasa, Laura
  • Sánchez, Lourdes
Background: The growing emphasis on agri-food sustainability and the circular economy has promoted the valorization of dairy by-products, particularly whey, which has an estimated annual global production of approximately 200 million tons. Whey is a valuable source of proteins with nutritional and bioactive properties, and nearly half of its volume is processed into whey protein concentrate (WPC) and whey protein isolate (WPI). During WPI production, whey protein phospholipid concentrate (WPPC) is generated; however, its functional properties remain poorly characterized. The incorporation of bioactive compounds from bovine milk and its by-products into infant formulas and specialized products may contribute to gut, brain, and immune system health. Objective: This study aimed to characterize WPPC obtained from bovine whey and to evaluate its activity against Cronobacter sakazakii and rotavirus, as well as to assess the impact of conventional homogenization (CH) and ultra-high-pressure homogenization (UHPH) on this bioactivity. Methods: WPPC was obtained from industrial cheese whey through ultrafiltration and microfiltration. The resulting fractions were characterized by SDS-PAGE, laser diffraction (Mastersizer), and proteomic analysis, and were further compared with commercial WPPC. Conventional homogenization (25 MPa) and UHPH treatments (100–200 MPa) were applied using pilot plant-scale equipment. Antibacterial activity against C. sakazakii was evaluated by measuring bacterial growth and adhesion to Caco-2/TC7 cells, while antiviral activity against bovine rotavirus strain WC3 was assessed in MA104 cells using indirect immunofluorescence. Results: WPPC at a protein concentration of approximately 5 mg/mL inhibited C. sakazakii growth and adhesion to Caco-2/TC7 cells by ~40-50%, with both CH and UHPH enhancing the inhibitory activity of non-commercial WPPC by ~40%. WPPC achieved complete inhibition of rotavirus at concentrations above 0.25 mg/mL. The observed bioactivities appear to be mainly attributable to compounds with molecular weights greater than 30 kDa. Conclusion: WPPC exhibits significant antibacterial and antiviral activities, with antibacterial effects enhanced by homogenization treatments. UHPH emerges as a promising alternative to thermal pasteurization. These findings further expand current knowledge of WPPC functional properties and support its potential application as a functional ingredient in health-oriented food formulations. Keywords: cheese whey, WPPC, homogenization, ultra-high-pressure homogenization, rotavirus, Cronobacter sakazakii
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Bovine whey fractions restore epithelial barrier function under TNF-α/IFN-γ challenge in a Caco-2/HT29-MTX co-culture model

  • Rubio, Pablo
  • García, Laura
  • Layunta, Elena
  • Sánchez, Lourdes
  • Grasa, Laura
Inflammation-induced intestinal barrier dysfunction is a key feature of several gastrointestinal disorders. Bovine whey contains bioactive components with potential barrier-protective and immunomodulatory properties, although its activity may depend on fraction composition. In this study, the effects of whole bovine whey (BWW) and skimmed bovine whey (BSW) were evaluated in a differentiated Caco-2/TC7:HT29-MTX co-culture model exposed to basolateral TNF-α + IFN-γ (50 ng mL−1, 24 h). Cytokine treatment significantly reduced transepithelial electrical resistance (TEER), downregulated CLDN1 and CLDN3, increased IL-1β expression, and decreased MUC2 expression, whereas FITC-dextran permeability remained unchanged. Both whey fractions restored TEER to values comparable to control and also increased TEER under basal conditions. BWW attenuated cytokine-induced IL-1β upregulation, whereas BSW increased MUC2 expression under both basal and inflammatory conditions. These results indicate that BWW and BSW improve epithelial barrier function under inflammatory conditions through distinct functional activities.